Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Inflammation 1 Frailty 1

Interventions

Specimen Handling 71 Magnetic Resonance Spectroscopy 57 Biopsy 44 pembrolizumab 38 Carboplatin 32 Nivolumab 29 Cyclophosphamide 27 Radiotherapy 26 Radiation 25 Paclitaxel 24 Cisplatin 24 olaparib 21 Etoposide 19 Doxorubicin 18 durvalumab 17 Taxes 17 Radiotherapy, Intensity-Modulated 17 Dexamethasone 17 Bevacizumab 17 X-Rays 16 Vincristine 16 Prednisone 16 Immunoglobulin G 16 Disulfides 16 Cytarabine 15 Platinum 14 Leucovorin 14 Docetaxel 14 Pemetrexed 13 Lenalidomide 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × epigallocatechin gallate × 30 days × Clear all

NCT04553666 2026-05-07

ReFOCUS1

University of Rochester

Phase 2 Completed

24 enrolled 17 charts

Frailty, Inflammation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡